Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

A new type of nerve cell involved in itch perception was discovered.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

A new skin cancer can develop where shingles once occurred.

Relapsing polychondritis might be linked to alopecia areata due to immune system factors.

Immune cell-targeting biologics show potential for treating alopecia areata but need better-targeted therapies.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

Memory regulatory T cells need IL-7, not IL-2, to stay in peripheral tissues.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Tislelizumab can cause cutaneous lupus erythematosus.

A specific gene change is linked to severe hair loss.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

IL-13 protein is much higher in the skin of atopic dermatitis patients than in healthy skin.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

ILC1-like cells can cause alopecia areata by themselves.

Malondialdehyde-modified DNA may trigger an immune response in alopecia areata patients.

Allergic contact dermatitis may promote hair growth by activating hair follicle stem cells.

A 16-year-old girl with lupus symptoms improved with treatment despite negative ANA tests.

A woman with scalp lymphoma and hair loss improved with radiotherapy, highlighting the need for biopsies in similar cases.

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

MAIT cells may help fight COVID-19 but also contribute to severe inflammation.

CD8+ virtual memory T cells may cause hair loss in alopecia areata.

Injecting recipient splenocytes into donors' thymus can prevent graft-versus-host disease.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

Auto-antibody testing is a useful but not definitive tool in diagnosing interstitial lung diseases, and using a specific algorithm could make testing more cost-effective.

Increasing regulatory T cells may help treat alopecia areata by reducing autoimmunity and promoting hair growth.

Lung immune cells can be trained to better fight infections after a virus.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.